BioMarin Pharmaceutical (NASDAQ:BMRN) Releases Quarterly Earnings Results
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) posted its quarterly earnings data on Tuesday. The biotechnology company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.78 by ($0.23), Briefing.com reports. The company had revenue of $746.00 million for the quarter, compared to analysts’ expectations of $703.37 million. BioMarin Pharmaceutical had […]
30 Oct 10:48 · The Cerbat Gem